Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Pulmatrix, Inc. (PULM) Form S-3/A — Oct 2, 2026

$PULMForm S-3/AFiled Oct 2, 2026, 9:47 PM ET0001493152-26-045658Original filing

Pulmatrix filed Amendment No. 2 to its Form S-3 to register the resale of up to 491,607 shares of common stock by RCM Eos PIPE HOLDINGS, LLC — 454,546 conversion shares from 1,000 Series B Convertible Preferred shares plus 37,061 dividend shares. The preferred shares were sold in a March 26, 2026 private placement at a $2.20 conversion price with 8% per annum stock dividends. The registered shares represent roughly 13% of the company's 3,652,285 shares outstanding, and the prospectus explicitly warns of substantial dilution and potential downward pressure on the stock, which last traded at $1.57 on October 2, 2026.

Key figures

Offering Price
$2.20 conversion price
Shares Offered
491607
Shares Outstanding
3652285
Dividend rate
8% per annum
Dividend shares
37061
Dilution percent
~13%
Conversion shares
454546
Preferred stated value
$1,000 per share
Preferred shares issued
1000
Last sale price 2026 10 02
$1.57
Beneficial ownership blocker
9.99%

AI analysis

Red flags5 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    Pulmatrix, Inc. (PULM) Form S-3/A — Oct 2, 2026: AI Analysis | Signal8